Plexiform Neurofibroma Clinical Trials in Birmingham, Alabama
2 recruitingBirmingham, Alabama
Showing 1–2 of 2 trials
Recruiting
Phase 2
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Neurofibromatosis 1Plexiform Neurofibroma
University of Alabama at Birmingham200 enrolled15 locationsNCT06188741
Recruiting
Phase 1
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
NF1 MutationNeurofibroma, PlexiformNeurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)+1 more
Pasithea Therapeutics Corp.56 enrolled5 locationsNCT06961565